Clinical Trials
11 trialsNCT07152938 2025-09-15
AVR-CHEMO
Arab American University (Palestine)
Phase NA Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT06457464 2024-06-13
Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients
Assiut University
Not yet recruiting
NCT04836871 2023-07-13
Double Filtration Plasmapheresis Combined With Chemotherapy
Zhongnan Hospital
Phase 1 Unknown
NCT05429515 2022-06-23
Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
Peking Union Medical College Hospital
Phase 4 Not yet recruiting
NCT00003196 2019-12-27
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma
Fred Hutchinson Cancer Center
Phase NA Completed
NCT00993694 2017-04-17
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Vanderbilt University Medical Center
Completed
NCT02288741 2014-11-11
DSMM-II
WiSP Wissenschaftlicher Service Pharma GmbH
Phase 3 Completed
NCT00416897 2013-08-26
Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure
National Cancer Institute (NCI)
Phase 3 Completed
NCT00085345 2013-07-10
Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00112879 2013-07-10
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Withdrawn